BMY Q3'26 Earnings: EPS estimate is 1.10 USD

What happened

Bristol-Myers Squibb is set to announce its Q3'26 results on October 29, before the market opens at 6:59 AM ET. The revenue estimate is 12.73 billion USD and the EPS estimate is 1.10 USD.

Confirmed

Global impact / market context

Earnings per share, which means profit divided by shares outstanding, is estimated at 1.10 USD. If the company merely meets this estimate, it signals weaker profit per sale or higher costs than earlier quarters, which could reduce cash available for research and dividends.

Analyst inference

Prior quarters beat revenue and EPS estimates. The low Q3'26 EPS estimate suggests analysts expect a sharp slowdown, so the gap between reported and estimated results will shape investor positioning and expectations for future profit per sale.

Analyst inference

What to watch

1. Watch whether reported Q3'26 revenue and EPS beat the estimates of 12.73 billion USD and 1.10 USD, given prior quarters beat estimates. Confirmed
2. Compare reported revenue and EPS with the 12.73 billion USD and 1.10 USD estimates to judge whether the expected slowdown is real. Proposed
3. A miss on the 1.10 USD EPS estimate could pressure the stock, while a beat would suggest profit per sale held up better than feared. Analyst inference

Evidence

• Original source link unavailable